title: Association of Cerebrospinal Fluid Ferritin Level With Preclinical Cognitive Decline in APOE-ε4 Carriers.
authors.affiliation: The Florey Institute for Neuroscience and Mental Health, The University of Melbourne, Melbourne, Australia.
authors.forename: Scott
authors.initials: S
authors.lastname: Ayton
authors.affiliation: IBM Research-Australia, Melbourne, Australia3Cooperative Research Center for Mental Health, Melbourne, Australia.
authors.forename: Noel G
authors.initials: NG
authors.lastname: Faux
authors.affiliation: The Florey Institute for Neuroscience and Mental Health, The University of Melbourne, Melbourne, Australia3Cooperative Research Center for Mental Health, Melbourne, Australia.
authors.forename: Ashley I
authors.initials: AI
authors.lastname: Bush
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid; D053327:Apolipoprotein E4 / Q000134:cerebrospinal fluid / Q000235:genetics*; D060825:Cognitive Dysfunction / Q000134:cerebrospinal fluid* / Q000235:genetics*; D005260:Female; D005293:Ferritins / Q000134:cerebrospinal fluid*; D006801:Humans; D008297:Male; D009483:Neuropsychological Tests; D010446:Peptide Fragments / Q000134:cerebrospinal fluid
chemical_list: D016229:Amyloid beta-Peptides; D053327:Apolipoprotein E4; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42); D005293:Ferritins